vTv Therapeutics Announces 2019 Third Quarter Financial Results and Update
30 oct. 2019 17h30 HE
|
vTv Therapeutics Inc.
SimpliciT-1 Study of TTP399 in patients with type 1 diabetes fully-enrolled Elevage Study of azeliragon in patients with mild Alzheimer’s disease with type 2 diabetes actively enrolling HIGH POINT,...
Déclaration de Dave Prowten, président et chef de la direction de FRDJ Canada
12 août 2019 11h15 HE
|
Fondation de la recherche sur le diabète juvénile
TORONTO, 12 août 2019 (GLOBE NEWSWIRE) -- FRDJ suit de très près les développements en ce qui a trait à la récente annonce du Safe Importation Action Plan du Département de la Santé et des...
Statement by Dave Prowten, President and CEO JDRF Canada
12 août 2019 11h15 HE
|
Juvenile Diabetes Research Foundation Canada
TORONTO, Aug. 12, 2019 (GLOBE NEWSWIRE) -- JDRF has been closely monitoring developments rising from the recent announcement of a “Safe Importation Action Plan” by the United States Department of...
T1D Exchange Teams with Tidepool to Leverage Device Data for Groundbreaking Study of Type 1 Diabetes
29 nov. 2018 07h45 HE
|
T1D Exchange
BOSTON, Nov. 29, 2018 (GLOBE NEWSWIRE) -- T1D Exchange today announced a research partnership with Tidepool to better understand the link between patient reported experiences and the mild and...
T1D Exchange Launches One-Stop Resource for the Type 1 Diabetes Community
08 nov. 2018 07h45 HE
|
T1D Exchange
New Website Puts Patients at the Center of Accelerating Innovation and Improving Care BOSTON, Nov. 08, 2018 (GLOBE NEWSWIRE) -- T1D Exchange today announced the launch of a new T1DExchange.org...
JDRF celebrates Health Canada’s new licence for technology that will improve the lives of people with type 1 diabetes
10 oct. 2018 14h56 HE
|
Juvenile Diabetes Research Foundation Canada
Approval of Canada’s first Hybrid Closed-Loop System will help Canadians with type 1 diabetes keep their blood sugar levels in an optimal range for a greater amount of time TORONTO, Oct. 10, 2018 ...
Endocrinologist & Researcher Dr. Dara P. Schuster Named CEO of T1D Exchange
22 juin 2018 08h00 HE
|
T1D Exchange
BOSTON, June 22, 2018 (GLOBE NEWSWIRE) -- T1D Exchange, a patient-centered research organization dedicated to accelerating therapies and improving care for people with type 1 diabetes (T1D), today...
CORRECTING and REPLACING – Protomer Technologies Takes Top Prize in 2018 Diabetes Innovation Challenge
22 mai 2018 10h10 HE
|
T1D Exchange
In a release issued under the same headline earlier today by T1D Exchange please note that in the third paragraph of the release the name of the Protomer Technologies Founder and CEO should by Alborz...
Protomer Technologies Takes Top Prize in 2018 Diabetes Innovation Challenge
22 mai 2018 07h00 HE
|
T1D Exchange
BOSTON, May 22, 2018 (GLOBE NEWSWIRE) -- Protomer Technologies of Pasadena, CA, will receive $50,000 in cash and up to $150,000 of in-kind support as the winner of the 2018 Diabetes Innovation...
Media Advisory: Monday, May 21 - 2018 Diabetes Innovation Challenge Pitch Off
16 mai 2018 09h00 HE
|
T1D Exchange
ROYAL SONESTA BOSTON3:00 PM – 5:00 PM $250,000 IN CASH AND IN-KIND PRIZES TO BE AWARDED BOSTON, May 16, 2018 (GLOBE NEWSWIRE) -- Ten finalists, all academic researchers and early stage companies,...